Scan to find protein loss in digestive system tumors
Part of Cancer, Digestive system clinical trials.
This study tests a new imaging scan that helps doctors see where your body is losing protein, which can happen with digestive system tumors. The scan may help guide treatment to improve your protein levels and overall health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a tumor in your digestive system.
- You have low protein levels in your blood or symptoms of low protein.
- Your blood albumin level is below 30 g/L and your AAT level is above 80 ml/d.
- You have visible tumors on imaging scans.
- You are expected to live more than 3 months.
- You are not pregnant or nursing, and you do not have severe liver or kidney problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special PET/CT scan (called 68Ga-NYM096) to see if it can help find different types of cancer. The scan may help doctors get clearer pictures of where cancer is in your body.
This study tests a new way of taking pictures of tumors (metastases) using an upgraded gamma camera. The goal is to see if this new method produces clearer images, which could help doctors find and treat cancer better. Participation is only for people who are already having a bone scan or a scan after certain types of radiation therapy.
This study uses a special scan (molecular imaging) to see how well antibody-drug conjugates (ADCs) work in people with breast cancer. It may help doctors choose the right treatment for you.
This trial uses a special imaging test (PET scan) to find digestive system cancers. It uses molecules that attach to cancer cells so they light up on the scan, which may help doctors see tumors more clearly.
This trial uses a special PET scan to see if a new imaging agent can find a protein called claudin 18.2 on cancer cells in pancreatic, stomach, or gastroesophageal junction cancers. The scan may help doctors better see the cancer and guide treatment decisions.
This study tests an imaging scan using a special tracer (68Ga-HA-DOTATATE) to look for tumors that have somatostatin receptors. It may help doctors better locate suspected tumor sites so treatment planning can be more accurate.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.